Technical Analysis for TYP - Tryptamine Therapeutics Limited
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| A | 0.054 | 14.89% | 0.007 |
TYP closed up 14.89 percent on Wednesday, November 13, 2024, on 2.82 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Nov 22
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | N/A | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing High | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Wide Range Bar | Range Expansion | 0.00% | |
| New 52 Week High | Strength | 0.00% | |
| Parabolic Rise | Strength | 0.00% | |
| Upper Bollinger Band Walk | Strength | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Above Upper BB | Strength | 0.00% | |
| Overbought Stochastic | Strength | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% |
| Alert | Time |
|---|---|
| Possible Pocket Pivot | 1 day ago |
| Possible Inside Day | 1 day ago |
| 3x Volume Pace | 1 day ago |
| Rose Above Upper Bollinger Band | 1 day ago |
| Up 1 ATR | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Tryp Therapeutics Inc., a clinical-stage pharmaceutical development company, focuses on developing psilocybin-related molecules in Canada and the United States. Its lead program candidate TRP-8803, a proprietary formulation of IV-infused psilocin that completed Phase 2a clinical trial for the treatment of binge eating disorder, fibromyalgia, abdominal pain, and visceral tenderness. The company's program candidate TRP-8802, a synthetic and oral psilocybin for the treatment of binge eating, chronic pain, and other indications. The company was formerly known as Artos Pharma Corp. and changed its name to Tryp Therapeutics Inc. in June 2020. Tryp Therapeutics Inc. was incorporated in 2019 and is based in Kelowna, Canada.
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Development
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Development
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.057 |
| 52 Week Low | 0.017 |
| Average Volume | 3,612,295 |
| 200-Day Moving Average | 0.000 |
| 50-Day Moving Average | 0.023 |
| 20-Day Moving Average | 0.031 |
| 10-Day Moving Average | 0.039 |
| Average True Range | 0.004 |
| RSI (14) | 77.68 |
| ADX | 46.62 |
| +DI | 48.130 |
| -DI | 3.577 |
| Chandelier Exit (Long, 3 ATRs) | 0.044 |
| Chandelier Exit (Short, 3 ATRs) | 0.031 |
| Upper Bollinger Bands | 0.052 |
| Lower Bollinger Band | 0.009 |
| Percent B (%b) | 1.05 |
| BandWidth | 139.672 |
| MACD Line | 0.007 |
| MACD Signal Line | 0.005 |
| MACD Histogram | 0.0024 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.069 | ||||
| Resistance 3 (R3) | 0.068 | 0.063 | 0.067 | ||
| Resistance 2 (R2) | 0.063 | 0.059 | 0.063 | 0.066 | |
| Resistance 1 (R1) | 0.058 | 0.056 | 0.061 | 0.059 | 0.065 |
| Pivot Point | 0.053 | 0.053 | 0.054 | 0.053 | 0.053 |
| Support 1 (S1) | 0.048 | 0.049 | 0.051 | 0.049 | 0.043 |
| Support 2 (S2) | 0.043 | 0.046 | 0.043 | 0.042 | |
| Support 3 (S3) | 0.038 | 0.043 | 0.042 | ||
| Support 4 (S4) | 0.039 |
